OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer statistics in China, 2015
Wanqing Chen, Rongshou Zheng, Peter D. Baade, et al.
CA A Cancer Journal for Clinicians (2016) Vol. 66, Iss. 2, pp. 115-132
Open Access | Times Cited: 16345

Showing 1-25 of 16345 citing articles:

Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Changfa Xia, Xuesi Dong, Li He, et al.
Chinese Medical Journal (2022) Vol. 135, Iss. 5, pp. 584-590
Open Access | Times Cited: 2664

Nasopharyngeal carcinoma
Yu‐Pei Chen, Anthony T.�C. Chan, Quynh‐Thu Le, et al.
The Lancet (2019) Vol. 394, Iss. 10192, pp. 64-80
Closed Access | Times Cited: 2363

Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
Wei Cao, Hongda Chen, Yiwen Yu, et al.
Chinese Medical Journal (2021) Vol. 134, Iss. 7, pp. 783-791
Open Access | Times Cited: 2205

Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing, Fengming Yang, Chuchu Shao, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 1584

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Mengyuan Dai, Dianbo Liu, Miao Liu, et al.
Cancer Discovery (2020) Vol. 10, Iss. 6, pp. 783-791
Open Access | Times Cited: 1543

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Ruimei Feng, Yi‐Nan Zong, Su‐Mei Cao, et al.
Cancer Communications (2019) Vol. 39, Iss. 1, pp. 1-12
Open Access | Times Cited: 1500

Epidemiology of Esophageal Squamous Cell Carcinoma
Christian C. Abnet, Melina Arnold, Wenqiang Wei
Gastroenterology (2017) Vol. 154, Iss. 2, pp. 360-373
Open Access | Times Cited: 1349

Epidemiology of ovarian cancer: a review
Reid Brett M., Reid Brett M., Permuth Jennifer B., et al.
Cancer Biology and Medicine (2017) Vol. 14, Iss. 1, pp. 9-32
Open Access | Times Cited: 1327

Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries
Hongmei Zeng, Wanqing Chen, Rongshou Zheng, et al.
The Lancet Global Health (2018) Vol. 6, Iss. 5, pp. e555-e567
Open Access | Times Cited: 1259

Cancer incidence and mortality in China, 2016
Rongshou Zheng, Siwei Zhang, Hongmei Zeng, et al.
Journal of the National Cancer Center (2022) Vol. 2, Iss. 1, pp. 1-9
Open Access | Times Cited: 1212

Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng, Mia Spezia, Shifeng Huang, et al.
Genes & Diseases (2018) Vol. 5, Iss. 2, pp. 77-106
Open Access | Times Cited: 1184

Global burden of primary liver cancer in 2020 and predictions to 2040
Harriet Rumgay, Melina Arnold, Jacques Ferlay, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1598-1606
Open Access | Times Cited: 1151

Epidemiology and determinants of obesity in China
Xiong‐Fei Pan, Limin Wang, An Pan
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 6, pp. 373-392
Closed Access | Times Cited: 1078

Cancer incidence and mortality in China, 2014
Wanqing Chen, Kexin Sun, Rongshou Zheng, et al.
Chinese Journal of Cancer Research (2018) Vol. 30, Iss. 1, pp. 1-12
Open Access | Times Cited: 976

Oesophageal cancer
Elizabeth Smyth, Jesper Lagergren, Rebecca C. Fitzgerald, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 816

Cancer incidence and mortality in China, 2022
Bingfeng Han, Rongshou Zheng, Hongmei Zeng, et al.
Journal of the National Cancer Center (2024) Vol. 4, Iss. 1, pp. 47-53
Open Access | Times Cited: 781

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
Zhenggang Ren, Jianming Xu, Yuxian Bai, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 7, pp. 977-990
Closed Access | Times Cited: 774

Physical activity, exercise, and chronic diseases: A brief review
Elizabeth Anderson, J. Larry Durstine
Sports Medicine and Health Science (2019) Vol. 1, Iss. 1, pp. 3-10
Open Access | Times Cited: 688

Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma
Zhigang Ren, Ang Li, Jianwen Jiang, et al.
Gut (2018) Vol. 68, Iss. 6, pp. 1014-1023
Open Access | Times Cited: 599

The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention
Zhenqiu Liu, Yanfeng Jiang, Huangbo Yuan, et al.
Journal of Hepatology (2018) Vol. 70, Iss. 4, pp. 674-683
Closed Access | Times Cited: 592

Global trends and predictions in hepatocellular carcinoma mortality
Paola Bertuccio, Federica Turati, Greta Carioli, et al.
Journal of Hepatology (2017) Vol. 67, Iss. 2, pp. 302-309
Closed Access | Times Cited: 575

CGCG clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang, Ying Mao, Wenbin Ma, et al.
Cancer Letters (2016) Vol. 375, Iss. 2, pp. 263-273
Open Access | Times Cited: 554

Page 1 - Next Page

Scroll to top